| Lastest Insider Transactions Of Y-mAbs Therapeutics, Inc. ( YMAB ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | CHIEF BUSINESS OFFICER | 2024-09-19 | Option Exercise | 22,831 | 4.38 | 100,000 | 2024-09-20 16:15:04 |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | CHIEF BUSINESS OFFICER | 2024-09-13 | Sell | 95,000 | 13.31 | 1,264,650 | 2024-09-17 20:05:37 |
| YMAB | Y-mAbs Therapeutics, Inc. | Ber Gerard | Directior | 2024-06-10 | Sell | 722 | 12.00 | 8,664 | 2024-06-11 19:54:20 |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | CHIEF BUSINESS OFFICER | 2024-06-10 | Sell | 70,000 | 12.02 | 841,050 | 2024-06-11 19:53:11 |
| YMAB | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, SECRY & TREAS. | 2024-05-30 | Sell | 60,000 | 12.05 | 723,055 | 2024-05-31 21:36:00 |
| YMAB | Y-mAbs Therapeutics, Inc. | Kruse Bo | EVP, CFO, SECRY & TREAS. | 2024-05-30 | Option Exercise | 60,000 | 2.00 | 120,000 | 2024-05-31 21:36:00 |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | CHIEF BUSINESS OFFICER | 2024-05-21 | Sell | 32,351 | 12.23 | 395,563 | 2024-05-23 18:54:43 |
| YMAB | Y-mAbs Therapeutics, Inc. | Rajah Vignesh | SVP & CHIEF MEDICAL OFFICER | 2024-03-05 | Sell | 1,711 | 16.53 | 28,283 | 2024-03-07 17:02:07 |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | CHIEF BUSINESS OFFICER | 2024-03-05 | Sell | 3,900 | 16.44 | 64,116 | 2024-03-07 17:01:09 |
| YMAB | Y-mAbs Therapeutics, Inc. | Smith Susan Laura | SVP & CHIEF COMMERCIAL OFFICER | 2024-03-05 | Sell | 1,682 | 16.55 | 27,837 | 2024-03-07 16:59:59 |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | Chief Business Officer | 2023-12-21 | Option Exercise | 50,000 | 2.00 | 100,000 | 2023-12-26 16:15:24 |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | Chief Business Officer | 2023-12-13 | Sell | 150,000 | 6.67 | 1,001,000 | 2023-12-15 19:40:50 |
| YMAB | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Directior | 2023-12-11 | Buy | 6,455 | 6.85 | 44,232 | 2023-12-12 08:27:16 |
| YMAB | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Directior | 2023-12-11 | Buy | 6,455 | 6.85 | 44,232 | 2023-12-12 08:26:25 |
| YMAB | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Directior | 2023-12-07 | Buy | 127,549 | 6.98 | 890,411 | 2023-12-11 17:25:50 |
| YMAB | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Directior | 2023-12-07 | Buy | 127,549 | 6.98 | 890,411 | 2023-12-11 17:25:09 |
| YMAB | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Directior | 2023-11-29 | Buy | 51,837 | 5.97 | 309,477 | 2023-12-01 17:15:32 |
| YMAB | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Directior | 2023-11-29 | Buy | 51,837 | 5.97 | 309,477 | 2023-12-01 17:14:55 |
| YMAB | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Directior | 2023-11-27 | Buy | 93,187 | 5.59 | 521,294 | 2023-11-29 17:15:53 |
| YMAB | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Directior | 2023-11-27 | Buy | 93,187 | 5.59 | 521,294 | 2023-11-29 17:14:49 |
| YMAB | Y-mAbs Therapeutics, Inc. | Gad Thomas | Chief Business Officer | 2023-11-20 | Sell | 150,000 | 5.30 | 795,383 | 2023-11-22 17:00:50 |
| YMAB | Y-mAbs Therapeutics, Inc. | Wedell-Wedellsborg Johan | Directior | 2023-05-15 | Buy | 101,740 | 9.65 | 981,404 | 2023-05-17 17:07:47 |
| YMAB | Y-mAbs Therapeutics, Inc. | WG Biotech ApS | Directior | 2023-05-15 | Buy | 101,740 | 9.65 | 981,404 | 2023-05-17 17:05:30 |
